BP’s Alexion Pharmaceuticals ALXN Stock Holding History

BP’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,084	Closed	-$934K	–	576
2021 Q2	$934K	Sell	5,084 -2,054	-29%	-$353K	0.04%	256
2021 Q1	$1.09M	Sell	7,138 -2,216	-24%	-$343K	0.04%	275
2020 Q4	$1.46M	Sell	9,354 -10,946	-54%	-$1.41M	0.04%	242
2020 Q3	$2.32M	Sell	20,300 -1,700	-8%	-$183K	0.06%	257
2020 Q2	$2.47M	Hold	22,000	–	–	0.09%	238
2020 Q1	$1.98M	Hold	22,000	–	–	0.08%	235
2019 Q4	$2.38M	Buy	22,000 +500	+2%	+$53.5K	0.08%	257
2019 Q3	$2.1M	Sell	21,500 -500	-2%	-$56.4K	0.08%	277
2019 Q2	$2.88M	Hold	22,000	–	–	0.11%	217
2019 Q1	$2.97M	Sell	22,000 -4,000	-15%	-$497K	0.12%	207
2018 Q4	$2.53M	Hold	26,000	–	–	0.11%	213
2018 Q3	$3.61M	Hold	26,000	–	–	0.11%	208
2018 Q2	$3.23M	Hold	26,000	–	–	0.1%	219
2018 Q1	$2.9M	Hold	26,000	–	–	0.11%	231
2017 Q4	$3.11M	Hold	26,000	–	–	0.11%	222
2017 Q3	$3.65M	Hold	26,000	–	–	0.13%	205
2017 Q2	$3.16M	Hold	26,000	–	–	0.12%	223
2017 Q1	$3.15M	Buy	26,000 +19,000	+271%	+$2.45M	0.12%	217
2016 Q4	$856K	Hold	7,000	–	–	0.03%	415
2016 Q3	$858K	Hold	7,000	–	–	0.03%	384
2016 Q2	$817K	Hold	7,000	–	–	0.03%	337
2016 Q1	$975K	Sell	7,000 -13,000	-65%	-$1.91M	0.04%	306
2015 Q4	$3.81M	Sell	20,000 -7,000	-26%	-$1.22M	0.16%	178
2015 Q3	$4.22M	Hold	27,000	–	–	0.19%	153
2015 Q2	$4.88M	Sell	27,000 -1,000	-4%	-$173K	0.18%	168
2015 Q1	$4.85M	Sell	28,000 -3,000	-10%	-$543K	0.15%	177
2014 Q4	$5.74M	Buy	+31,000	New	+$5.74M	0.15%	165

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

BP's ALXN Position: Q3 2021 in Review

BP sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5,084 shares — an estimated $934K sold.

BP first reported a position in ALXN in Q4 2014 and held it in 27 quarters. The position peaked at $5.74M in Q4 2014. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

BP reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
BP sold 5,084 Alexion Pharmaceuticals shares in Q3 2021, an estimated $934K.
BP first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 27 quarters.
BP's Alexion Pharmaceuticals position peaked at $5.74M in Q4 2014.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.